Literature DB >> 11921291

Genomic organization and expression of the rearranged REL proto-oncogene in the human B-cell lymphoma cell line RC-K8.

Demetrios Kalaitzidis1, Thomas D Gilmore.   

Abstract

The human large B-cell lymphoma cell line RC-K8 has a rearranged REL locus that is transcribed into a chimeric mRNA, termed REL-NRG (Non-Rel Gene). By analyzing the recently completed human genome sequence, we have found that the normal REL and NRG loci are separated by approximately 28 megabase pairs on chromosome 2, suggesting that a deletion created the REL-NRG locus in RC-K8 cells. Using computer-based and molecular approaches, we have determined the structure of the altered REL locus in RC-K8 cells. The REL-NRG transcript is encoded by 7 REL exons and 6 NRG-derived exons. Direct DNA sequencing has identified the site of the REL-NRG fusion in RC-K8 cells. We also show that both wild-type c-Rel and c-Rel-Nrg proteins are expressed and in a complex in RC-K8 cells. Furthermore, like c-Rel, c-Rel-Nrg is a cytoplasmic protein when overexpressed in fibroblasts in culture and can bind to a kappaB DNA site in vitro. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11921291     DOI: 10.1002/gcc.10051

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

1.  Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL.

Authors:  J R Leeman; M A Weniger; T F Barth; T D Gilmore
Journal:  Oncogene       Date:  2008-08-11       Impact factor: 9.867

2.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

3.  A rearranged EP300 gene in the human B-cell lymphoma cell line RC-K8 encodes a disabled transcriptional co-activator that contributes to cell growth and oncogenicity.

Authors:  Michael R Garbati; Ryan C Thompson; Leila Haery; Thomas D Gilmore
Journal:  Cancer Lett       Date:  2011-01-12       Impact factor: 8.679

4.  Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile.

Authors:  M Chin; M Herscovitch; N Zhang; D J Waxman; T D Gilmore
Journal:  Oncogene       Date:  2009-04-20       Impact factor: 9.867

5.  Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8.

Authors:  Michael R Garbati; Gökçen Alço; Thomas D Gilmore
Journal:  Cancer Lett       Date:  2009-11-30       Impact factor: 8.679

6.  Evidence for an oncogenic modifier role for mutant histone acetyltransferases in diffuse large B-cell lymphoma.

Authors:  Leila Haery; Sultan Mussakhan; David J Waxman; Thomas D Gilmore
Journal:  Leuk Lymphoma       Date:  2016-03-22

Review 7.  The Direct and Indirect Roles of NF-κB in Cancer: Lessons from Oncogenic Fusion Proteins and Knock-in Mice.

Authors:  Tabea Riedlinger; Jana Haas; Julia Busch; Bart van de Sluis; Michael Kracht; M Lienhard Schmitz
Journal:  Biomedicines       Date:  2018-03-19

Review 8.  Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma.

Authors:  Stefanie Kewitz; Ines Volkmer; Martin S Staege
Journal:  Cancer Growth Metastasis       Date:  2013-08-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.